Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study.

MLA

Wei, Yu-Ce, et al. “Intensive Therapy Can Improve Long-Term Survival in Newly Diagnosed, Advanced-Stage Extranodal NK/T-Cell Lymphoma: A Multi-Institutional, Real-World Study.” International Journal of Cancer, vol. 153, no. 9, Nov. 2023, pp. 1643–57. EBSCOhost, https://doi.org/10.1002/ijc.34672.

APA

Wei, Y.-C., Qi, F., Zheng, B.-M., Zhang, C.-G., Xie, Y., Chen, B., Liu, W.-X., Liu, W.-P., Fang, H., Qi, S.-N., Zhang, D., Chai, Y., Li, Y.-X., Wang, W.-H., Song, Y.-Q., Zhu, J., & Dong, M. (2023). Intensive therapy can improve long-term survival in newly diagnosed, advanced-stage extranodal NK/T-cell lymphoma: A multi-institutional, real-world study. International Journal of Cancer, 153(9), 1643–1657. https://doi.org/10.1002/ijc.34672

Chicago

Wei, Yu-Ce, Fei Qi, Bao-Min Zheng, Chang-Gong Zhang, Yan Xie, Bo Chen, Wei-Xin Liu, et al. 2023. “Intensive Therapy Can Improve Long-Term Survival in Newly Diagnosed, Advanced-Stage Extranodal NK/T-Cell Lymphoma: A Multi-Institutional, Real-World Study.” International Journal of Cancer 153 (9): 1643–57. doi:10.1002/ijc.34672.